A Study to Evaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease (ABBY)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
This is a Phase II, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the safety and efficacy of MABT5102A in patients with mild to moderate Alzheimer\'s Disease.
Epistemonikos ID: 281946935006548f6400bfeb5b723241f61f354f
First added on: May 06, 2024